Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2011 Apr 5;20(5):799–810. doi: 10.1158/1055-9965.EPI-10-1180

Table 4.

Odds ratios and 95% confidence intervals by inflammatory profile

Cytokine vs. Modulator Low/Low Low/High High/Low High/High
IL-1β vs. IL-1Ra
 # cases/# controls 72/139 39/85 42/71 77/137
 OR (95% CI) 1.0 (ref) 0.91 (0.57, 1.47) 1.15 (0.71, 1.85) 1.09 (0.73, 1.64)
 p-value 0.71 0.57 0.67
IL-1β vs. sIL-1Rll
 # cases/# controls 46/105 65/119 70/109 49/99
 OR (95% CI) 1.0 (ref) 1.20 (0.76, 1.92) 1.43 (0.90, 2.27) 1.11 (0.68, 1.81)
 p-value 0.43 0.13 0.69
IL-2 vs. sIL-2Ra
 # cases/# controls 48/118 59/107 63/99 60/108
 OR (95% CI) 1.0 (ref) 1.36 (0.85, 2.19) 1.56 (0.98, 2.47) 1.36 (0.85, 2.16)
 p-value 0.20 0.06 0.20
IL-4 vs. sIL-4R
 # cases/# controls 61/121 44/103 53/95 72/113
 OR (95% CI) 1.0 (ref) 0.85 (0.53, 1.36) 1.11 (0.70, 1.76) 1.28 (0.84, 1.97)
 p-value 0.50 0.65 0.25
IL-6 vs. sIL-6R
 # cases/# controls 52/116 51/110 68/94 59/112
 OR (95% CI) 1.0 (ref) 1.05 (0.66, 1.68) 1.65 (1.05, 2.61) 1.19 (0.76, 1.89)
 p-value 0.84 0.03 0.45
IL-12p70 vs. IL-12p40
 # cases/# controls 49/129 54/100 58/96 69/107
 OR (95% CI) 1.0 (ref) 1.46 (0.92, 2.34) 1.62 (1.01, 2.58) 1.74 (1.11, 2.74)
 p-value 0.11 0.04 0.02
TNFα vs. sTNF-R1
 # cases/# controls 48/137 67/83 62/85 63/127
 OR (95% CI) 1.0 (ref) 2.12 (1.30, 3.45) 2.13 (1.33, 3.41) 1.51 (0.95, 2.41)
 p-value 0.002 0.002 0.08
TNFα vs. sTNF-R2
 # cases/# controls 62/129 43/91 53/86 72/126
 OR (95% CI) 1.0 (ref) 0.98 (0.61, 1.58) 1.28 (0.81, 2.03) 1.18 (0.76, 1.82)
 p-value 0.94 0.29 0.46

Note: Each marker was classified as high or low based on the median value and then four groups were created for each pair. Models are unconditional logistic regression models, adjusted for the matching factors (age, cohort, menopausal status)